Sign in with your email address username.


[Correspondence] Time to recognise countries’ preferences in HIV control

While The Lancet stated that the new WHO antiretroviral therapy (ART) guidelines are ambitious,1 Granich and Williams (Jan 2, p 27) called for the implementation of a “test-and-treat strategy” to achieve the goals of the 90-90-90 target and epidemic control.2 They stated that this strategy fits within the global budget and implied that countries’ HIV budgets should be first and foremost spent on putting all individuals with HIV on ART. However, their suggestions overlooked HIV control preferences at the country level, where goals other than epidemic control might also be considered important.